We are very happy to announce that the call for Amsterdam UMC TKI-PPP grants is now open. For the first time the TKI grant procedures from AMC and VUmc will be combined (now that VUmc has also been allowed by Health~Holland to evaluate its own projects)! This means that the grant amounts available to both our UMCs will be combined, creating a pot of approximately 8 million euros that will be divided over the best PPP-research proposals that we will receive from all of you.
For those of you who are unfamiliar with TKI grants and PPP-proposals, please click here to download the TKI-PPP flyer in which we explain all abbreviations, the details of the grant procedure, how proposals will be evaluated, and where the money comes from.
Those of you who have a proposal in mind and a private partner to collaborate with are invited to prepare and send in a pre-application using the form and budget sheet below no later than the deadline of December 9. In addition, a Letter of Intent from each private partner is required at this stage (see template below).
The Consortium Agreement (also below) comes in slightly different variants, depending on the number of industrial and/or academic partners. For now we have only attached a 1-on-1 version. Please provide your industrial partner(s) with this draft Consortium Agreement at an early stage, allowing your partner(s) to get acquainted with the conditions that they will need to accept once your joint application is awarded.
We look forward to receiving your proposals!
2. Budget form
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News